Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Dose Escalation in KIT Exon 9 Mutated GIST
NCT01541709Phase 2Active, not recruiting
- Sponsor
- Asan Medical Center
- Start
- Mar 2012
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Asan Medical Center. Started Mar 2012; status: active, not recruiting.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01541709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541709.